Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Open Access
- 10 February 2023
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (5) , 338.e1-338.e6
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (HL007057-46)
This publication has 27 references indexed in Scilit:
- Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell CocultureNew England Journal of Medicine, 2012
- HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell diseaseBlood, 2012
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated DonorsNew England Journal of Medicine, 2012
- Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftmentExperimental Hematology, 2012
- Ex vivo expansion of human hematopoietic stem and progenitor cellsBlood, 2011
- Donor Cell–Derived Leukemias/Myelodysplastic Neoplasms in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAmerican Journal of Clinical Pathology, 2011
- Donor-Derived Second Hematologic Malignancies after Cord Blood TransplantationTransplantation and Cellular Therapy, 2010
- Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitutionNature Medicine, 2010
- Ex vivo expansion of cord bloodBone Marrow Transplantation, 2009
- Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood BankCytotherapy, 2007